After years of work on efforts to control 2 major tropical diseases, researchers have reported important developments that may lead to a malaria vaccine and a treatment for Ebola virus infection.
One team of researchers demonstrated in a small, preliminary trial that intravenous injections of purified cryopreserved Plasmodium falciparum sporozoites can successfully protect individuals against malaria infection. A second group found in a small study in rhesus macaques that a cocktail of monoclonal antibodies derived from plants may substantially reduce the risk of death from Ebola, even after clinical symptoms appear.
Kuehn BM. Malaria Vaccine, Ebola Therapy Promising in Early Studies. JAMA. 2013;310(13):1327–1328. doi:10.1001/jama.2013.278188
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: